Samuel E Driver from 23 Felix St, Providence, RI 02908, age 54

Isbn (Books And Publications)

Kings I and II : Critical and Exegetical Commentary

view source

Author
Samuel R. Driver

ISBN #
0567050068

Amos and Hosea : Critical and Exegetical Commentary

view source

Author
Samuel R. Driver

ISBN #
0567050181

St. Luke : Critical and Exegetical Commentary

view source

Author
Samuel R. Driver

ISBN #
0567050238

A Critical and Exegetical Commentary: The Book of Job

view source

Author
Samuel R. Driver

ISBN #
0567050106

Us Patents

Genetic Inhibition By Double-Stranded Rna
view source
US Patent:

6506559, Jan 14, 2003
Filed:

Dec 18, 1998
Appl. No.:

09/215257
Inventors:

Andrew Fire - Baltimore MD
Stephen Kostas - Chicago IL
Mary Montgomery - St. Paul MN
Lisa Timmons - Lawrence KS
SiQun Xu - Ballwin MO
Hiroaki Tabara - Shizuoka, JP
Samuel E. Driver - Providence RI
Craig C. Mello - Shrewsbury MA
Assignee:

Carnegie Institute of Washington - Washington DC
International Classification:

C12Q 168
US Classification:

435 6, 435 911, 435325
Abstract:

A process is provided of introducing an RNA into a living cell to inhibit gene expression of a target gene in that cell. The process may be practiced ex vivo or in vivo. The RNA has a region with double-stranded structure. Inhibition is sequence-specific in that the nucleotide sequences of the duplex region of the RNA and of a portion of the target gene are identical. The present invention is distinguished from prior art interference in gene expression by antisense or triple-strand methods.

Transplacental Delivery Of Oligonucleotides
view source
US Patent:

6576218, Jun 10, 2003
Filed:

Oct 18, 2001
Appl. No.:

09/982465
Inventors:

Peter C. Roberts - Holliston MA
Samuel E. Driver - Brighton MA
Assignee:

Quantitative Informational Knockout Technology - Providence RI
International Classification:

A61K 4800
US Classification:

424 91, 424 92, 514 44, 536 245
Abstract:

This invention provides synthetic oligonucleotides that are useful for transplacental delivery, the oligonucleotides being DNA or RNA or both, preferably between 12-35 nucleotides in length, having a stabilized and charged backbone and at least one chemically modified base or sugar moiety, wherein the modified base or sugar moiety facilitates transplacental delivery.

Genetic Inhibition By Double-Stranded Rna
view source
US Patent:

7538095, May 26, 2009
Filed:

Oct 30, 2002
Appl. No.:

10/282996
Inventors:

Andrew Fire - Baltimore MD, US
Stephen Kostas - Chicago IL, US
Mary Montgomery - St. Paul MN, US
Lisa Timmons - Lawrence KS, US
SiQun Xu - Ballwin MO, US
Hiroaki Tabara - Shizuoka, JP
Samuel E. Driver - Providence RI, US
Craig C. Mello - Shrewsbury MA, US
Assignee:

The Carnegie Institution of Washington - Washington DC
The University of Massachusetts - Boston MA
International Classification:

A61K 31/70
C07H 21/04
C12N 5/00
C12N 15/00
C12Q 1/68
C12P 19/34
US Classification:

514 44, 536 245, 435 6, 435 913, 4353201, 435325
Abstract:

A process is provided of introducing an RNA into a living cell to inhibit gene expression of a target gene in that cell. The process may be practiced ex vivo or in vivo. The RNA has a region with double-stranded structure. Inhibition is sequence-specific in that the nucleotide sequences of the duplex region of the RNA and of a portion of the target gene are identical. The present invention is distinguished from prior art interference in gene expression by antisense or triple-strand methods.

Genetic Inhibition By Double-Stranded Rna
view source
US Patent:

7560438, Jul 14, 2009
Filed:

Oct 30, 2002
Appl. No.:

10/283190
Inventors:

Andrew Fire - Baltimore MD, US
Stephen Kostas - Chicago IL, US
Mary Montgomery - St. Paul MN, US
Lisa Timmons - Lawrence KS, US
SiQun Xu - Ballwin MO, US
Hiroaki Tabara - Shizuoka, JP
Samuel E. Driver - Providence RI, US
Craig C. Mello - Shrewsbury MA, US
Assignee:

The Carnegie Institution of Washington - Washington DC
The University of Massachusetts - Boston MA
International Classification:

A61K 31/70
C07H 21/04
C12N 5/00
C12N 15/00
C12Q 1/68
C12P 19/34
US Classification:

514 44, 536 235, 435 6, 435 913, 4353201, 435325
Abstract:

A process is provided of introducing an RNA into a living cell to inhibit gene expression of a target gene in that cell. The process may be practiced ex vivo or in vivo. The RNA has a region with double-stranded structure. Inhibition is sequence-specific in that the nucleotide sequences of the duplex region of the RNA and of a portion of the target gene are identical. The present invention is distinguished from prior art interference in gene expression by antisense or triple-strand methods.

Genetic Inhibition By Double-Stranded Rna
view source
US Patent:

7622633, Nov 24, 2009
Filed:

Oct 30, 2002
Appl. No.:

10/283267
Inventors:

Andrew Fire - Baltimore MD, US
Stephen Kostas - Chicago IL, US
Mary Montgomery - St. Paul MN, US
Lisa Timmons - Lawrence KS, US
SiQun Xu - Ballwin MO, US
Hiroaki Tabara - Shizuoka, JP
Samuel E. Driver - Providence RI, US
Craig C. Mello - Shrewsbury MA, US
Assignee:

Carnegie Institution of Washington - Washington DC
International Classification:

C12N 15/82
C12N 15/90
C12N 5/10
US Classification:

800285, 435468
Abstract:

A process is provided of introducing an RNA into a living cell to inhibit gene expression of a target gene in that cell. The process may be practiced ex vivo or in vivo. The RNA has a region with double-stranded structure. Inhibition is sequence-specific in that the nucleotide sequences of the duplex region of the RNA and of a portion of the target gene are identical. The present invention is distinguished from prior art interference in gene expression by antisense or triple-strand methods.

Genetic Inhibition By Double-Stranded Rna
view source
US Patent:

20080050342, Feb 28, 2008
Filed:

Jul 13, 2007
Appl. No.:

11/826385
Inventors:

Andrew Fire - Baltimore MD, US
Stephen Kostas - Chicago IL, US
Mary Montgomery - St. Paul MN, US
Lisa Timmons - Lawrence KS, US
SiQun Xu - Ballwin MO, US
Hiroaki Tabara - Shizuoka, JP
Samuel Driver - Providence RI, US
Craig Mello - Shrewsbury MA, US
International Classification:

A61K 31/7105
A01H 5/00
A61K 48/00
C12N 1/00
A61P 43/00
A01K 67/00
US Classification:

424093200, 435243000, 514044000, 800013000, 800295000
Abstract:

A process is provided of introducing an RNA into a living cell to inhibit gene expression of a target gene in that cell. The process may be practiced ex vivo or in vivo. The RNA has a region with double-stranded structure. Inhibition is sequence-specific in that the nucleotide sequences of the duplex region of the RNA and of a portion of the target gene are identical. The present invention is distinguished from prior art interference in gene expression by antisense or triple-strand methods.

Genetic Inhibition By Double-Stranded Rna
view source
US Patent:

20130029425, Jan 31, 2013
Filed:

Jul 25, 2012
Appl. No.:

13/557995
Inventors:

Andrew Fire - Baltimore MD, US
Stephen Kostas - Chicago IL, US
Mary Montgomery - St. Paul MN, US
Lisa Timmons - Lawrence KS, US
SiQun Xu - Ballwin MO, US
Hiroaki Tabara - Mishima, JP
Samuel E. Driver - Providence RI, US
Craig C. Mello - Shrewsbury MA, US
International Classification:

C12N 15/82
US Classification:

435468, 4353201
Abstract:

A process is provided of introducing an RNA into a living cell to inhibit gene expression of a target gene in that cell. The process may be practiced ex vivo or in vivo. The RNA has a region with double-stranded structure. Inhibition is sequence-specific in that the nucleotide sequences of the duplex region of the RNA and of a portion of the target gene are identical. The present invention is distinguished from prior art interference in gene expression by antisense or triple-strand methods.

Genetic Inhibition By Double-Stranded Rna
view source
US Patent:

20130230492, Sep 5, 2013
Filed:

Oct 8, 2012
Appl. No.:

13/647177
Inventors:

Mary Montgomery - St. Paul MN, US
Lisa Timmons - Lawrence KS, US
SiQun Xu - Ballwin MO, US
Hiroaki Tabara - Mishima, JP
Samuel E. Driver - Providence RI, US
Craig C. Mello - Shrewsbury MA, US
Assignee:

THE UNIVERSITY OF MASSACHUSETTS - Boston MA
CARNEGIE INSTITUTION OF WASHINGTON - Washington DC
International Classification:

A61K 31/713
C12N 15/82
C12N 15/85
US Classification:

424 932, 435375, 435419, 514 44 A
Abstract:

A process is provided of introducing an RNA into a living cell to inhibit gene expression of a target gene in that cell. The process may be practiced ex vivo or in vivo. The RNA has a region with double-stranded structure. Inhibition is sequence-specific in that the nucleotide sequences of the duplex region of the RNA and of a portion of the target gene are identical. The present invention is distinguished from prior art interference in gene expression by antisense or triple-strand methods.

Wikipedia

Samuel Rolles Driver

view source

Samuel Rolles Driver (October 2, 1846 - February 26, 1914) was an English divine and Hebrew scholar. He devoted his life to the study, both textual and critical, of

Samuel Driver

view source

Samuel Driver may refer to: Samuel Rolles Driver (1846-1914), English divine and Hebrew scholar; Samuel Marion Driver (18921958), United States Federal Judge